To bring world class pharmaceutical science expertise to address issues of medicines quality in resource-constrained settings
Our team collaborates with international and low- and middle-income countries stakeholders to identify and investigate issues of substandard and falsified medicines, and implement systemic improvements through evidence generation, capacity building, advocacy and training. Our aim is to generate evidence and share expertise to strengthen regulatory systems, support global and national policy change and inform strategic procurement and better supply chain management.
Learn more about our research news and publications here.
